New Herpes Zoster (Shingles) Vaccine Guidance for Immunocompromised Travelers
Planning a trip while managing an immune condition? The National Advisory Committee on Immunization (NACI) now strongly recommends that all immunocompromised adults age 18+ receive two doses of the shingles (herpes zoster) vaccine—even if you’re under age 50.
Why this matters for travelers:
- Stress, jet lag, and disrupted routines can weaken your immune system, raising your risk of shingles reactivation while abroad.
- Herpes zoster can cause severe nerve pain, rash, and long-term complications—a serious disruption to any travel itinerary.
- The Shingrix® vaccine (RZV) offers 65–90% protection and is safe for most immunocompromised individuals.
We recommend completing both doses (2–6 months apart) at least 2 weeks before departure—especially if you’re starting immunosuppressive therapy soon.
Are you immunocompromised or on medications that weaken your immune system?
This includes people living with:
- HIV
- Cancer
- Autoimmune diseases
- Transplant history
- Long-term steroid use or biologic therapies
Don’t let shingles derail your plans.
Book your pre-travel health consultation with Destinations Travel Clinic to review your vaccine needs—including Shingrix and others required for your trip.
Contact us today to stay protected while exploring the world!
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied upon for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer
